BACKGROUND: Parkinson's disease (PD) impacts several domains of functioning, some of which may be neglected when designing treatment or evaluating outcome using current clinical standards. We therefore argue that taking the patients' perspectives of their condition may allow for a more in-depth assessment of patient goals and subsequent tailoring of care. METHODS: One hundred and forty-eight patients with idiopathic PD completed a modified version of the Patient-Centered Outcomes Questionnaire (PCOQ-PD), to evaluate treatment success and expectations from the patient's perspective across 10 motor and non-motor functional domains. We also examined patient subgroups based on importance of improvement in various domains. RESULTS: Patients' ratings suggested there was substantial variation in functional interference that was generally unrelated to demographic variables. On average, across all domains, patients indicated a 50.32% reduction in symptoms would be successful (range = 40.63-58.23%), regardless of treatment experience. Change scores between patients' usual levels of symptom interference and their treatment success levels suggested a greater degree of change was desired in motor versus non-motor domains (p < 0.05). Finally, cluster analyses revealed two patient subgroups based on overall importance of improvement (High vs. Low Importance Endorsement). Notably, the two groups differed in self-reported usual symptom levels despite having similar clinical severity. CONCLUSIONS: We empirically examined treatment success from the PD patient's view as opposed to clinician judgment alone, thereby broadening the set of criteria by which to evaluate outcome. Findings from this exploratory study may guide future treatment emphases and guide patient-provider communication via clarification of patient-defined success.
BACKGROUND:Parkinson's disease (PD) impacts several domains of functioning, some of which may be neglected when designing treatment or evaluating outcome using current clinical standards. We therefore argue that taking the patients' perspectives of their condition may allow for a more in-depth assessment of patient goals and subsequent tailoring of care. METHODS: One hundred and forty-eight patients with idiopathic PD completed a modified version of the Patient-Centered Outcomes Questionnaire (PCOQ-PD), to evaluate treatment success and expectations from the patient's perspective across 10 motor and non-motor functional domains. We also examined patient subgroups based on importance of improvement in various domains. RESULTS:Patients' ratings suggested there was substantial variation in functional interference that was generally unrelated to demographic variables. On average, across all domains, patients indicated a 50.32% reduction in symptoms would be successful (range = 40.63-58.23%), regardless of treatment experience. Change scores between patients' usual levels of symptom interference and their treatment success levels suggested a greater degree of change was desired in motor versus non-motor domains (p < 0.05). Finally, cluster analyses revealed two patient subgroups based on overall importance of improvement (High vs. Low Importance Endorsement). Notably, the two groups differed in self-reported usual symptom levels despite having similar clinical severity. CONCLUSIONS: We empirically examined treatment success from the PDpatient's view as opposed to clinician judgment alone, thereby broadening the set of criteria by which to evaluate outcome. Findings from this exploratory study may guide future treatment emphases and guide patient-provider communication via clarification of patient-defined success.
Authors: Rodrigo Mercado; Constantine Constantoyannis; Tomasz Mandat; Ajit Kumar; Michael Schulzer; A Jon Stoessl; Christopher R Honey Journal: Mov Disord Date: 2006-09 Impact factor: 10.338
Authors: Jennifer L Brown; Penny S Edwards; James W Atchison; Ann Lafayette-Lucey; Virgil T Wittmer; Michael E Robinson Journal: Pain Med Date: 2008-10 Impact factor: 3.750
Authors: Pablo Martínez-Martín; Julian Benito-León; Fernando Alonso; M José Catalán; Margarita Pondal; Aurelio Tobías; Ivana Zamarbide Journal: Mov Disord Date: 2003-09 Impact factor: 10.338
Authors: Danielle B Tometich; Catherine E Mosher; Adam T Hirsh; Kevin L Rand; Shelley A Johns; Marianne S Matthias; Samantha D Outcalt; Bryan P Schneider; Lida Mina; Anna Maria V Storniolo; Erin V Newton; Kathy D Miller Journal: Support Care Cancer Date: 2018-05-07 Impact factor: 3.603
Authors: Catharina Sjödahl Hammarlund; Maria H Nilsson; Markus Idvall; Scott R Rosas; Peter Hagell Journal: Qual Life Res Date: 2014-01-04 Impact factor: 4.147
Authors: Shinichi Amano; Joe R Nocera; Srikant Vallabhajosula; Jorge L Juncos; Robert J Gregor; Dwight E Waddell; Steven L Wolf; Chris J Hass Journal: Parkinsonism Relat Disord Date: 2013-07-05 Impact factor: 4.891
Authors: Danielle M Wojtkiewicz; James Saunders; Leahthan Domeshek; Christine B Novak; Vicki Kaskutas; Susan E Mackinnon Journal: Hand (N Y) Date: 2015-06
Authors: Matej Skorvanek; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Radka Ghorbani Saeedian; Johan W Groothoff; Zuzana Gdovinova; Jitse P van Dijk Journal: J Neurol Date: 2013-01-09 Impact factor: 4.849
Authors: Jaimie A Roper; Nyeonju Kang; Juliana Ben; James H Cauraugh; Michael S Okun; Chris J Hass Journal: J Neurol Date: 2016-04-28 Impact factor: 4.849